China is moving quickly to formalize gene editing in agriculture as part of a broader food security and innovation agenda, with the Ministry of Agriculture and Rural Affairs (MARA) serving as the key regulator for agricultural genome editing. China has built a centralized, government led review pathway intended to distinguish lower risk gene edits from higher risk alterations while keeping oversight centralized and technical.
The shift became concrete in January 2022, when MARA issued the Guidelines for Safety Evaluation of Gene Edited Plants for Agricultural Use. The Guidelines set out application procedures and safety requirements for gene edited plants, with emphasis on edits that do not introduce exogenous genetic sequences.
China is now using this system in practice. MARA has begun issuing biosafety certificates for gene edited crop events. According to the USDA FAS Biotechnology and Other New Production Technologies Annual 2025 report (CH2025-0224), China approved early gene edited events in 2023 and 2024, and on December 31, 2024 MARA issued a tranche that included five new certificates for gene edited events approved for domestic cultivation and production. The approved gene edited pipeline described in that report includes soybean quality and yield traits, corn yield traits, wheat disease resistance and herbicide tolerance traits, and rice quality traits.
At the same time, China’s system still shows a gap between certification and full market rollout. The same USDA FAS annual report notes that even with gene edited wheat and rice events approved, missing variety registration standards can prevent commercialization. In other words, China now has a functioning approval mechanism for gene edited crops, but the final step from event approval to widely available commercial varieties can still be slowed by downstream registration rules.
For animals, the picture is less advanced. China has extensive research activity, but it has not issued biosafety certificates for agricultural gene edited animals, meaning there are no approved food producing gene edited livestock or aquaculture species intended for the human food chain. The USDA FAS annual report also reports that MARA has been developing “Guidelines for the Safety Evaluation of Gene Edited Animals for Agricultural Use,” and that these guidelines are under review with feedback solicited from stakeholders and experts.
In sum, China has built a defined pathway for gene edited crops and is issuing approvals, but commercialization is still constrained by the practical mechanics of variety registration. For food producing animals, including aquaculture species intended for human consumption, China remains in a pre commercial phase, with draft guidance still under review and no approvals yet for market use.
NGO Reaction
China’s move toward regulated gene edited crops has not produced a highly visible, organized domestic NGO campaign aimed directly at MARA’s gene editing pathway, but “public trust” remains a recurring theme in policy discussion. Academic analysis of China’s genome edited crop rules has explicitly argued that regulators must strengthen governance in ways that enhance public trust, rather than treating technical approval as sufficient for long term legitimacy.
Where civil society pressure is most likely to bite is transparency and enforcement. USDA reporting notes that beginning in 2025 MARA stopped publishing newly approved biosafety certificates, warning this could raise public concerns about regulatory transparency, which is precisely the kind of governance issue advocacy networks tend to elevate when scrutiny increases.
Among China facing advocacy organizations, Greenpeace East Asia, which maintains offices including in Beijing, has historically framed agricultural biotechnology concerns around oversight and enforcement, for example through a Greenpeace East Asia investigation that emphasized unauthorized biotech presence in the food system. Publicly available English language interventions of this type focus less on the fine distinctions among NGT categories and more on compliance, monitoring, and governance capacity as agricultural biotechnology expands.
Updated: 04/08/2026
